Durrmeyer Xavier, Walter-Nicolet Elizabeth, Chollat Clément, Chabernaud Jean-Louis, Barois Juliette, Chary Tardy Anne-Cécile, Berenguer Daniel, Bedu Antoine, Zayat Noura, Roué Jean-Michel, Beissel Anne, Bellanger Claire, Desenfants Aurélie, Boukhris Riadh, Loose Anne, Massudom Tagny Clarisse, Chevallier Marie, Milesi Christophe, Tauzin Manon
Neonatal Intensive Care Unit, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
Université Paris Est Créteil, Faculté de Santé de Créteil, IMRB, GRC CARMAS, Créteil, France.
Front Pediatr. 2023 Jan 4;10:1075184. doi: 10.3389/fped.2022.1075184. eCollection 2022.
Laryngoscopy is frequently required in neonatal intensive care. Awake laryngoscopy has deleterious effects but practice remains heterogeneous regarding premedication use. The goal of this statement was to provide evidence-based good practice guidance for clinicians regarding premedication before tracheal intubation, less invasive surfactant administration (LISA) and laryngeal mask insertion in neonates.
A group of experts brought together by the French Society of Neonatology (SFN) addressed 4 fields related to premedication before upper airway access in neonates: (1) tracheal intubation; (2) less invasive surfactant administration; (3) laryngeal mask insertion; (4) use of atropine for the 3 previous procedures. Evidence was gathered and assessed on predefined questions related to these fields. Consensual statements were issued using the GRADE methodology.
Among the 15 formalized good practice statements, 2 were strong recommendations to do (Grade 1+) or not to do (Grade 1-), and 4 were discretionary recommendations to do (Grade 2+). For 9 good practice statements, the GRADE method could not be applied, resulting in an expert opinion. For tracheal intubation premedication was considered mandatory except for life-threatening situations (Grade 1+). Recommended premedications were a combination of opioid + muscle blocker (Grade 2+) or propofol in the absence of hemodynamic compromise or hypotension (Grade 2+) while the use of a sole opioid was discouraged (Grade 1-). Statements regarding other molecules before tracheal intubation were expert opinions. For LISA premedication was recommended (Grade 2+) with the use of propofol (Grade 2+). Statements regarding other molecules before LISA were expert opinions. For laryngeal mask insertion and atropine use, no specific data was found and expert opinions were provided.
This statement should help clinical decision regarding premedication before neonatal upper airway access and favor standardization of practices.
新生儿重症监护中经常需要进行喉镜检查。清醒喉镜检查有不良影响,但在使用术前用药方面,实践仍存在差异。本声明的目的是为临床医生提供基于证据的关于新生儿气管插管、微创表面活性剂给药(LISA)和喉罩插入术前用药的良好实践指南。
由法国新生儿学会(SFN)召集的一组专家探讨了与新生儿上气道通路术前用药相关的4个领域:(1)气管插管;(2)微创表面活性剂给药;(3)喉罩插入;(4)前3种操作中阿托品的使用。收集并评估了与这些领域相关的预定义问题的证据。使用GRADE方法发布了共识声明。
在15条正式的良好实践声明中,2条是强烈建议做(1+级)或不做(1-级),4条是酌情建议做(2+级)。对于9条良好实践声明,GRADE方法无法应用,因此形成了专家意见。对于气管插管,除危及生命的情况外,术前用药被认为是必要的(1+级)。推荐的术前用药是阿片类药物+肌肉阻滞剂联合使用(2+级),或在无血流动力学损害或低血压的情况下使用丙泊酚(2+级),而不鼓励单独使用阿片类药物(1-级)。关于气管插管前其他药物的声明是专家意见。对于LISA,建议进行术前用药(2+级),使用丙泊酚(结果:在15条正式的良好实践声明中,2条是强烈建议做(1+级)或不做(1-级),4条是酌情建议做(2+级)。对于9条良好实践声明,GRADE方法无法应用,因此形成了专家意见。对于气管插管,除危及生命的情况外,术前用药被认为是必要的(1+级)。推荐的术前用药是阿片类药物+肌肉阻滞剂联合使用(2+级),或在无血流动力学损害或低血压的情况下使用丙泊酚(2+级),而不鼓励单独使用阿片类药物(1-级)。关于气管插管前其他药物的声明是专家意见。对于LISA,建议进行术前用药(2+级),使用丙泊酚(2+级)。关于LISA前其他药物的声明是专家意见。对于喉罩插入和阿托品的使用,未找到具体数据,因此提供了专家意见。
本声明应有助于新生儿上气道通路术前用药的临床决策,并促进实践的标准化。 2+级)。关于LISA前其他药物的声明是专家意见。对于喉罩插入和阿托品的使用,未找到具体数据,因此提供了专家意见。
本声明应有助于新生儿上气道通路术前用药的临床决策,并促进实践的标准化。